Simplifying regulatory complexity for better products to be available to patients faster.
Read moreGeneva, 23 November 2016 – After seven years as Director General, Eduardo Pisani announced today his decision to leave the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), representing the leading research-based biopharmaceutical companies as well as national and regional industry associations across the world. IFPMA is based in Geneva and has formal consultative...
Read moreThis video illustrates the different surveillance activities needed to target the right virus before the manufacturing process begins.
Read moreVaccines are considered one of the most successful and cost-effective public health interventions, protecting us from many infectious and childhood diseases. In fact, over the past 50 years, vaccines have saved more lives worldwide than any other medical product or procedure.
Read moreCLICK IN THE IMAGE ABOVE PLEASE
Read morePharmacists’ role in flu prevention According to recent World Health Organization (WHO) data, in South America flu and other respiratory viruses declined in most countries. Overall, taking the flu shot is the best way to avoid the flu. When fewer people get the vaccine, the virus spreads more quickly, meaning more people are exposed to it and...
Read moreSince its inception in 1980, the International Conference of the Drug Regulatory Authorities (ICDRA) represents a major platform for WHO and drug regulatory authorities across its member states, in their efforts to harmonize regulation and improve the safety, efficacy, and quality of medicines. The focus of this year’s ICDRA Conference held in Cape Town at...
Read more